CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
8.13
0.49%
Market Trading Hours* (UTC) Opens on Monday at 08:00

Mon: 08:00 - 16:30

Tue: 08:00 - 12:55

Fri: 08:00 - 16:30

  • Summary
  • Historical Data
Trading сonditions
Spread 0.05
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.019346 %
Charges from full value of position ($-3.68)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.019346%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.002876 %
Charges from full value of position ($-0.55)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.002876%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency EUR
Margin 5.00%
Stock exchange Spain
Commission on trade 0%

Key Stats
Prev. Close 8.17
Open 8.11
1-Year Change -6.35%
Day's Range 8.03 - 8.17
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 20, 2024 8.13 0.06 0.74% 8.07 8.17 8.00
Dec 19, 2024 8.17 -0.12 -1.45% 8.29 8.34 8.12
Dec 18, 2024 8.27 0.05 0.61% 8.22 8.32 8.15
Dec 17, 2024 8.13 -0.21 -2.52% 8.34 8.39 8.13
Dec 16, 2024 8.39 0.11 1.33% 8.28 8.39 8.26
Dec 13, 2024 8.31 0.09 1.09% 8.22 8.34 8.22
Dec 12, 2024 8.27 0.02 0.24% 8.25 8.34 8.22
Dec 11, 2024 8.30 0.06 0.73% 8.24 8.36 8.23
Dec 10, 2024 8.34 0.03 0.36% 8.31 8.44 8.21
Dec 9, 2024 8.35 0.06 0.72% 8.29 8.38 8.22
Dec 6, 2024 8.31 -0.20 -2.35% 8.51 8.56 8.28
Dec 5, 2024 8.49 -0.04 -0.47% 8.53 8.64 8.49
Dec 4, 2024 8.55 0.11 1.30% 8.44 8.63 8.42
Dec 3, 2024 8.50 -0.14 -1.62% 8.64 8.74 8.50
Dec 2, 2024 8.77 0.03 0.34% 8.74 8.83 8.61
Nov 29, 2024 8.84 0.11 1.26% 8.73 8.86 8.69
Nov 28, 2024 8.73 0.05 0.58% 8.68 8.75 8.64
Nov 27, 2024 8.66 0.26 3.10% 8.40 8.69 8.36
Nov 26, 2024 8.34 -0.12 -1.42% 8.46 8.52 8.34
Nov 25, 2024 8.50 0.03 0.35% 8.47 8.55 8.38

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Almirall Company profile

About Almirall SA

Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Almirall SA revenues increased 2% to EUR827.2M. Net loss totaled EUR40.9M vs. income of EUR74.3M. Revenues reflect Own Network (Spain) segment increase of 11% to EUR593.5M, Corporate segment increase of 3% to EUR27.1M, Spain segment increase of 5% to EUR250.2M, Europe/Middle East segment increase of 3% to EUR406.9M, Other Unallocated segment increase of 3% to EUR27.1M.

Equity composition

changed name from Laboratorios Almirall SA 5/2012, Scrip Issue, 1 new share for every 36 shares held (Factor: 1.02778).5/2013, Scrip Issue, 1 new share for every 68 shares held (Factor: 1.01471).5/2019, Scrip Issue, 1 new share for every 74 shares held (Factor: 1.01351).

Industry: Pharmaceuticals (NEC)

Ronda General Mitre, 151
BARCELONA
BARCELONA 08022
ES

People also watch

Gold

2,620.17 Price
-0.110% 1D Chg, %
Long position overnight fee -0.0151%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.30

US100

21,361.10 Price
+0.370% 1D Chg, %
Long position overnight fee -0.0234%
Short position overnight fee 0.0012%
Overnight fee time 22:00 (UTC)
Spread 1.8

ETH/USD

3,236.35 Price
-2.050% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

BTC/USD

94,299.35 Price
-2.610% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading